medical device tax

Mary Woolley's Weekly Letter: Keeping a finger on the public pulse

By Mary Woolley on March 28, 2019

Dear Research Advocate: Speaking recently to the “New Voices” group at the National Academies of Science, Engineering and Medicine, as well as to young scientists during a visit to the University of Miami, I was energized by the passion, determination and commitment they all have for engaging the public. I discussed highlights of the survey findings we feature in Research!America’s new poll data summary A new survey question probes awareness and support for engagement of scientists in the policy making process. Other survey highlights include trend data that might surprise you — like the 10% increase since 2015 in those who say they would be willing to pay more in taxes if the money went to...

Mary Woolley's Weekly Letter: Countering threats to science and to health

By Mary Woolley on February 14, 2019

Dear Research Advocate: The Congress is poised to pass, and the President appears ready to sign, a final FY19 spending package, averting another shutdown. Of note, the summary of the bill text indicates a $269 million (9%) increase for FDA, bringing its total FY19 budget to $3.08 billion, and a $307.6 million (4%) increase for NSF, bringing its total budget to $8.1 billion. Research!America joined with other science community leaders and Nobel Laureates earlier this week on a letter to members of Congress and the President, calling attention to the considerable negative effects of the recent partial shutdown as well as the need to avoid another costly impasse. There had been rumors that the...

Mary Woolley's Weekly Letter: Down to the wire -- again

By Mary Woolley on December 13, 2018

Dear Research Advocate: Research!America had the opportunity this week to attend a Senate NIH Caucus meeting featuring Dr. Jennifer Doudna, the world-renowned biochemist at UC Berkeley, who is a pioneer in the field of gene editing. A big thank you to Jed Manocherian and ACT for NIH for working with Senator Dick Durbin (D-IL) to bring Dr. Doudna to Capitol Hill to discuss the powerful new technology known as CRISPR, which has potentially curative applications for diseases such as sickle cell and cancer. Here is a list of current Senate NIH Caucus members. Take a moment to send your Senators an email urging them to join if they are not already members. Congress has just six days to act...

A Weekly Advocacy Message from Mary Woolley: Summer in the Capital City

By Mary Woolley on August 9, 2018

Dear Research Advocate: With the recent nomination of atmospheric scientist Kelvin Droegemeier, PhD, to head the White House Office of Science and Technology Policy (OSTP), I have been asked about the role of this office and its director. In this terrific analysis , Former OSTP assistant director Tom Kalil lays it all out and also offers compelling observations on the nature of effective leadership. Anyone interested in public service, policy-making or policy-influencing, and/or honing leadership skills, would do well to spend a few minutes with “Policy Entrepreneurship at the White House.” Research!America sent a letter to Senate Commerce, Science, Transportation Committee Chair John Thune...

A Weekly Advocacy Message from Mary Woolley: An unacceptable scenario

By Mary Woolley on December 14, 2017

Dear Research Advocate: This week marks the one year anniversary of the signing of the 21st Century Cures Act. Ominously, momentum to accomplish the goals of this ground-breaking, bipartisan legislation and so much more could be forced off track by events of the last few hours: release by House leadership of a “hybrid” continuing resolution/Department of Defense bill that would fully fund FY18 Defense spending ($640B) while flat- funding everything else until (at least) January 19. The January 19th deadline wasn’t pulled out of thin air; that is the deadline for congressional action to prevent an across-the-board spending cut to meet the FY18 budget caps. The ‘hybrid’ proposal would...

A Weekly Advocacy Message from Mary Woolley: News and Coming Attractions

By Mary Woolley on November 9, 2017

Dear Research Advocate: This just in: advocacy works. The four provisions in the National Defense Authorization Act (NDAA) that posed a threat to the Congressionally Directed Medical Research Program (CDMRP) have been removed from the conference report. We owe a special thank you to our congressional champions Senators Richard Durbin (D-IL) and Roy Blunt (R-MO) and Representatives Ryan Costello (R-PA), Peter King (R-NY), Sanford Bishop (D-GA) and Dave Loebsack (D-IA). Next, let’s make advocacy work for federal funding. Congress has only 14 legislative days to act before the current continuing resolution (CR) expires on December 8. From what we are hearing, the chances of an FY18 budget deal...

A Weekly Advocacy Message from Mary Woolley: 2017 is off to a fast start

By Mary Woolley on January 5, 2017

Dear Research Advocate, Washington is back in full swing. Members of Congress were sworn in on January 3 and started working right away on a budget resolution to facilitate repeal of the Affordable Care Act (ACA). While repeal appears inevitable, it’s a fact that the public and policymakers continue to be of two --or more! - minds about what a replacement should look like. The crucial importance of continuity extends beyond insurance coverage to include the Prevention and Public Health Fund (PPHF), the Patient Centered Outcomes Research Institute (PCORI) ,and the Center for Medicare and Medicaid Innovation (CMMI). I don’t want to overwhelm you with advocacy asks: please use this advocacy...

A weekly advocacy message from Mary Woolley: A win for patients, for research and for advocacy

By Mary Woolley on December 17, 2015

Dear Research Advocate, This holiday season, Congress has delivered a most welcome package with plenty of trimmings for patients and all of us who care about the future of health. The bipartisan deal-making is complete. A final short-term spending measure, expiring Tuesday, December 22, allows the House and Senate time to review and pass a spending bill and tax package before adjourning for the year. These two major pieces of legislation represent a real win for research; the jumpstart we need to restore the NIH budget to robust annual growth and fuel a new era of medical innovation and global leadership in both public and private sectors. As federal policymakers consider how to vote on...

A weekly advocacy letter from Mary Woolley: Advocates talk to Congress

By Mary Woolley on June 18, 2015

Dear Research Advocate: Several patient groups, including Autism Speaks and the Lupus Foundation of America, were here in force this week, bringing hundreds of patients from around the nation to Capitol Hill to make their very personal, and powerful, cases for research. Their timing was perfect, as it coincided with the push for 21st Century Cures cosponsors, and subcommittee passage of the House “Labor-H” appropriations bill for fiscal year (FY) 2016, which covers funding for NIH, CDC, and AHRQ. This funding bill is definitely a mixed bag. NIH would receive a $1.1 billion increase; $100 million above the President’s budget. CDC would also receive an increase of $140 million, equal to the...

Research!America urges the 114th Congress to Advance Top 5 Science Priorities in First 100 Days

By researchamerica on January 7, 2015

Today, Research!America urged the 114th Congress to take action on five science priorities in the first 100 days of the legislative session in order to elevate research and innovation on the nation’s agenda: Advance the 21st Century Cures Initiative. Spearheaded by Representatives Fred Upton (R-Mich.) and Diana DeGette (D-Colo.),the initiative is a promising step in the right direction, focusing on speeding medical progress from bench-to-bedside by integrating patient perspectives into the regulatory process, modernizing clinical trials, and reducing red tape, among other things. Repeal the medical device tax. A provision in the Affordable Care Act, efforts to repeal the medical device tax...

medical device tax

Mary Woolley's Weekly Letter: Keeping a finger on the public pulse

Mary Woolley's Weekly Letter: Countering threats to science and to health

Mary Woolley's Weekly Letter: Down to the wire -- again

A Weekly Advocacy Message from Mary Woolley: Summer in the Capital City

A Weekly Advocacy Message from Mary Woolley: An unacceptable scenario

A Weekly Advocacy Message from Mary Woolley: News and Coming Attractions

A Weekly Advocacy Message from Mary Woolley: 2017 is off to a fast start

A weekly advocacy message from Mary Woolley: A win for patients, for research and for advocacy

A weekly advocacy letter from Mary Woolley: Advocates talk to Congress

Research!America urges the 114th Congress to Advance Top 5 Science Priorities in First 100 Days

Pages

Twitter

Tags

Blogroll

Previous Posts

Take Action

How Can I Help?

Sidebar Quote